Atlas Trials

Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)

Clinical trial NCT05361161 · UNKNOWN

Trial details

NCT number
NCT05361161
Sponsor
Gang Wu
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerEmbolization
Start date
2022-06-01
Primary completion
2022-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.